Please provide your email address to receive an email when new articles are posted on . A novel SK ion channel inhibitor more often converted atrial fibrillation to sinus rhythm compared with placebo.

HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties, excellent tolerability and a ...

Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

A research group led by Assistant Professor Megumi Aimoto and Professor Akira Takahara at the Faculty of Pharmaceutical Sciences, Toho University, revealed that pyrazole-3 (Pyr3), a selective ...

Despite being the most common form of cardiac arrhythmia, atrial fibrillation (AFib) is a condition that often goes undiagnosed and/or untreated. The condition, which often accompanies other health ...

A brand new procedure to treat atrial fibrillation is now being offered at several hospitals across Colorado after UCHealth in Loveland successfully completed the first procedure in the state. c "Afib ...

DISCLAIMER: I am not a medical professional. If you believe you have AFib or any other heart/medical condition that needs attention, please consult with your personal medical provider. You may be in ...

Share on Pinterest New research suggests that there may be more than 10.5 million people in the United States living with atrial fibrillation, that is, three times more cases than experts had ...

Drinking caffeinated coffee is safe for people with atrial fibrillation and may help protect against recurrence of the disorder, a new study finds. More than 10 million Americans live with atrial ...